Trial Profile
A double blind, randomized, multicentre study of amlodipine/valsartan versus valsartan in Chinese hypertensive patients.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 01 Dec 2015
Price :
$35
*
At a glance
- Drugs Amlodipine/valsartan (Primary)
- Indications Hypertension
- Focus Therapeutic Use
- 01 Dec 2015 New trial record